Progress of the tumorigenic mechanism of neutrophil and its relevance to pre-metastatic niche

Abstract

吴玉亮，程忠平. Progress of the tumorigenic mechanism of neutrophil and its relevance to pre-metastatic niche[J]. Journal of International Oncology, 2017, 44(11): 846-848.

［1］ Coffelt SB, Wellenstein MD, de Visser KE. Neutrophils in cancer: neutral no more［J］. Nat Rev Cancer, 2016, 16(7): 431-446. DOI: 10.1038/nrc.2016.52. ［2］ Fridlender ZG, Sun J, Kim S, et al. Polarization of tumorassociated neutrophil phenotype by TGFbeta: "N1" versus "N2" TAN［J］. Cancer cell, 2009, 16(3): 183-194. DOI: 10.1016/j.ccr.2009.06.017. ［3］ Fridlender ZG, Albelda SM. Tumorassociated neutrophils: friend or foe?［J］. Carcinogenesis, 2012, 33(5): 949955. DOI: 10.1093/carcin/bgs123. ［4］ Andzinski L, Kasnitz N, Stahnke S, et al. Type Ⅰ IFNs induce antitumor polarization of tumor associated neutrophils in mice and human［J］. Int J Cancer, 2016, 138(8): 1982-1993. DOI: 10.1002/ijc.29945. ［5］ Galdiero MR, Garlanda C, Jaillon S, et al. Tumor associated macrophages and neutrophils in tumor progression［J］. J Cell Physiol, 2013, 228(7): 1404-1412. DOI: 10.1002/jcp.24260. ［6］ Raghuwanshi SK, Su Y, Singh V, et al. The chemokine receptors CXCR1 and CXCR2 couple to distinct G proteincoupled receptor kinases to mediate and regulate leukocyte functions［J］. J Immunol, 2012, 189(6): 28242832. DOI: 10.4049/jimmunol.1201114. ［7］ Henkels KM, Frondorf K, Gonzalezmejia ME, et al. IL8induced neutrophil chemotaxis is mediated by Janus kinase 3 (JAK3)［J］. FEBS Lett, 2011, 585(1): 159-166. DOI: 10.1016/j.febslet.2010.11.031. ［8］ UribeQuerol E, Rosales C. Neutrophils in cancer: two sides of the same coin ［J］. J Immunol Res, 2015, 2015: 983698. DOI: 10.1155/2015/983698. ［9］ Granot Z, Fridlender ZG. Plasticity beyond cancer cells and the "immunosuppressive switch"［J］. Cancer Res, 2015, 75(21): 4441-4445. DOI: 10.1158/0008-5472.can-15-1502. ［10］ Murdoch C, Monk P, Finn A. Cxc chemokine receptor expression on human endothelial cells［J］. Cytokine, 1999, 11(9): 704-712. DOI: 10.1006/cyto.1998.0465. ［11］ Curtis VF, Wang H, Yang P, et al. A PK2/Bv8/PROK2 antagonist suppresses tumorigenic processes by inhibiting angiogenesis in glioma and blocking myeloid cell infiltration in pancreatic cancer［J］. PLoS One, 2013, 8(1): e54916. DOI: 10.1371/journal.pone.0054916. ［12］ Deryugina EI, Zajac E, Junckerjensen A, et al. Tissueinfiltrating neutrophils constitute the major in vivo source of angiogenesisinducing MMP-9 in the tumor microenvironment ［J］. Neoplasia, 2014, 16(10): 77188, DOI:10.1016/j.neo.2014.08.013. ［13］ Deryugina EI, Quigley JP. Tumor angiogenesis: MMPmediated induction of intravasation and metastasissustaining neovasculature［J］. Matrix Biol, 2015, 44-46: 94-112. DOI: 10.1016/j.matbio.2015.04.004. ［14］ Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis［J］. Cell, 2017, 168(4): 670-691. DOI: 10.1016/j.cell.2016.11.037. ［15］ Spiegel A, Brooks MW, Houshyar S, et al. Neutrophils suppress intraluminal NK cellmediated tumor cell clearance and enhance extravasation of disseminated carcinoma cells［J］. Cancer Discov, 2016, 6(6): 630-649. DOI: 10.1158/2159-8290.CD-15-1157. ［16］ CoolsLartigue J, Spicer J, Mcdonald B, et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis［J］. J Clin Invest, 2013, pii: 67484. DOI: 10.1172/JCI67484. ［17］ Peinado H, Zhang H, Matei IR, et al. Pre-metastatic niches: organspecific homes for metastases［J］. Nat Rev Cancer, 2017, 17(5): 302-317. DOI: 10.1038/nrc.2017.6. ［18］ Becker A, Thakur BK, Weiss JM, et al. Extracellular vesicles in cancer: celltocell mediators of metastasis［J］. Cancer cell, 2016, 30(6): 836-848. DOI: 10.1016/j.ccell.2016.10.009. ［19］ Liu Y, Gu Y, Han Y, et al. Tumor exosomal RNAs promote lung premetastatic niche formation by activating alveolar epithelial TLR3 to recruit neutrophils［J］. Cancer Cell, 2016, 30(2): 243-256. DOI: 10.1016/j.ccell.2016.06.021. ［20］ Wculek SK, Malanchi I. Neutrophils support lung colonization of metastasisinitiating breast cancer cells［J］. Nature, 2015, 528(7582): 413-417. DOI: 10.1038/nature16140. ［21］ Yan HH, Pickup M, Pang Y, et al. Gr1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung［J］. Cancer Res, 2010, 70(15): 6139-6149. DOI: 10.1158/00085472.CAN-10-0706. ［22］ Wu CF, Andzinski L, Kasnitz N, et al. The lack of type Ⅰ interferon induces neutrophilmediated premetastatic niche formation in the mouse lung［J］. Int J Cancer, 2015, 137(4): 837-847. DOI: 10.1002/ijc.29444.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.

Progress of the tumorigenic mechanism of neutrophil and its relevance to pre-metastatic niche

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments